Table 2.
IPA analysis overview
Comparison | Analysis | Top networks | Score | Top Diseases and Disorders | p-Value | # of Molecules | Top Molecular and Cellular Functions | p-Value | # of Molecules |
---|---|---|---|---|---|---|---|---|---|
EnD vs. EnA | Transcriptomics | Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism | 48 | Cancer | < 0.0161 | 23 | Lipid Metabolism | < 0.0184 | 6 |
Lipid Metabolism, Small Molecule Biochemistry, Genetic Disorder | 30 | Hematological Disease | < 0.0132 | 12 | Small Molecule Biochemistry | < 0.0184 | 10 | ||
Gene Expression, Nutritional Disease, Cellular Development | 22 | Gastrointestinal Disease | < 0.0105 | 9 | Vitamin and Mineral Metabolism | < 0.0175 | 12 | ||
Proteomics & | Cellular Assembly and Organization, Nucleic Acid Metabolism, Small Molecule Biochemistry | 25 | Neurological Disease | < 0.0106 | 7 | Cellular Growth and Proliferation | < 0.0382 | 7 | |
Genetic Disorder | < 0.0486 | 8 | Cell Morphology | < 0.0297 | 4 | ||||
Cancer | < 0.0394 | 7 | Cellular Assembly and Organization | < 0.0346 | 6 | ||||
EnD vs. UPSC-A | Transcriptomics | Organism Injury and Abnormalities, Cardiac Necrosis/Cell Death, Cell Death* | 44 | Cancer | < 0.0196 | 31 | Cellular Growth and Proliferation | < 0.0212 | 28 |
Organ Morphology, Reproductive System Development and Function, Skeletal and Muscular Disorders # | 28 | Genetic Disorder | < 0.0234 | 47 | Cell-To-Cell Signaling and Interaction | < 0.0234 | 11 | ||
Cellular Development, Cellular Growth and Proliferation, Cancer | 20 | Reproductive System Disease | < 0.0196 | 12 | Cell Death | < 0.0234 | 26 | ||
Cardiovascular Disease, Hematological Disease, Skeletal and Muscular Disorders | 19 | ||||||||
Endocrine System Development and Function, Small Molecule Biochemistry, Gene Expression | 15 | ||||||||
Proteomics & | Lipid Metabolism, Small Molecule Biochemistry, Cell Morphology *, # | 25 | Cancer | < 0.0428 | 7 | Amino Acid Metabolism | < 0.0150 | 2 | |
Gastrointestinal Disease | < 0.0214 | 4 | Cell Morphology | < 0.010 | 1 | ||||
Inflammatory Disease | < 0.0479 | 2 | Cellular Assembly and Organization | < 0.0125 | 2 | ||||
EnA vs. UPSC-A | Transcriptomics | Cardiovascular System Development and Function, Cell Cycle, Lipid Metabolism | 28 | Cardiovascular Disease | < 0.0430 | 12 | Gene Expression | < 0.0245 | 7 |
Cell Death, Cellular Movement, Hematological System Development and Function | 28 | Development Disorder | < 0.0301 | 5 | Cell Death | < 0.0338 | 15 | ||
Cellular Assembly and Organization, Cellular Function and Maintenance, Cell Signaling | 22 | Connective Tissue Disorder | < 0.0487 | 9 | Cellular Movement | < 0.0485 | 8 |
& Refers to Gemoll et al. [18]
* Overlapping of marked networks via platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) dimer (PDGFBB)
# Overlapping of marked networks via beta-Actin (ACTB)
EnD, endometrioid diploid
EnA, endometrioid aneuploid
UPSC-A, UPSC aneuploid